MGNX
Price
$1.59
Change
+$0.13 (+8.84%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
93.23M
98 days until earnings call
Intraday BUY SELL Signals
TCRX
Price
$1.13
Change
-$0.06 (-5.04%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
67.53M
118 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MGNX vs TCRX

Header iconMGNX vs TCRX Comparison
Open Charts MGNX vs TCRXBanner chart's image
MacroGenics
Price$1.59
Change+$0.13 (+8.84%)
Volume$16.81K
Capitalization93.23M
TScan Therapeutics
Price$1.13
Change-$0.06 (-5.04%)
Volume$15.67K
Capitalization67.53M
MGNX vs TCRX Comparison Chart in %
MGNX
Daily Signal:
Gain/Loss:
TCRX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
MGNX vs. TCRX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGNX is a Hold and TCRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (MGNX: $1.47 vs. TCRX: $1.19)
Brand notoriety: MGNX and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MGNX: 108% vs. TCRX: 108%
Market capitalization -- MGNX: $100.9M vs. TCRX: $64.13M
MGNX [@Biotechnology] is valued at $100.9M. TCRX’s [@Biotechnology] market capitalization is $64.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MGNX’s FA Score shows that 0 FA rating(s) are green whileTCRX’s FA Score has 1 green FA rating(s).

  • MGNX’s FA Score: 0 green, 5 red.
  • TCRX’s FA Score: 1 green, 4 red.
According to our system of comparison, TCRX is a better buy in the long-term than MGNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MGNX’s TA Score shows that 4 TA indicator(s) are bullish while TCRX’s TA Score has 6 bullish TA indicator(s).

  • MGNX’s TA Score: 4 bullish, 6 bearish.
  • TCRX’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, TCRX is a better buy in the short-term than MGNX.

Price Growth

MGNX (@Biotechnology) experienced а +2.08% price change this week, while TCRX (@Biotechnology) price change was +4.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

MGNX is expected to report earnings on Feb 19, 2026.

TCRX is expected to report earnings on Mar 11, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGNX($93.2M) has a higher market cap than TCRX($67.5M). MGNX YTD gains are higher at: -54.769 vs. TCRX (-60.855). MGNX has higher annual earnings (EBITDA): -26.91M vs. TCRX (-130.55M). TCRX has more cash in the bank: 218M vs. MGNX (176M). MGNX has less debt than TCRX: MGNX (37.2M) vs TCRX (96.7M). MGNX has higher revenues than TCRX: MGNX (164M) vs TCRX (6.96M).
MGNXTCRXMGNX / TCRX
Capitalization93.2M67.5M138%
EBITDA-26.91M-130.55M21%
Gain YTD-54.769-60.85590%
P/E RatioN/AN/A-
Revenue164M6.96M2,356%
Total Cash176M218M81%
Total Debt37.2M96.7M38%
FUNDAMENTALS RATINGS
MGNX: Fundamental Ratings
MGNX
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
82
P/E GROWTH RATING
1..100
93
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MGNXTCRX
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 8 days ago
82%
Declines
ODDS (%)
Bearish Trend 8 days ago
86%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MGNX
Daily Signal:
Gain/Loss:
TCRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PEFDF0.65N/A
N/A
DELFI LTD
TSRYF3.55N/A
N/A
Treasury Wine Estates Ltd.
KRYAF93.00N/A
N/A
Kerry Group plc
TLTFF0.14-0.01
-4.48%
Theralase Technologies Inc.
TOBAF0.05-0.03
-37.07%
TAAT Global Alternatives Inc.

MGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGNX has been loosely correlated with CRBU. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if MGNX jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGNX
1D Price
Change %
MGNX100%
-3.29%
CRBU - MGNX
54%
Loosely correlated
+0.89%
RGNX - MGNX
53%
Loosely correlated
+0.43%
XNCR - MGNX
49%
Loosely correlated
-3.23%
BEAM - MGNX
49%
Loosely correlated
-2.71%
IDYA - MGNX
48%
Loosely correlated
-0.19%
More

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with MGNX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then MGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
-2.46%
MGNX - TCRX
41%
Loosely correlated
-3.29%
FATE - TCRX
40%
Loosely correlated
-7.14%
ELVN - TCRX
38%
Loosely correlated
+3.36%
CGEM - TCRX
38%
Loosely correlated
+7.05%
XNCR - TCRX
37%
Loosely correlated
-3.23%
More